MedWatch

The Lundbeck Foundation eyes Ferrosan IPO in 5 years

If Ferrosan Medical Devices continues down its current growth path, it could be ready for an initial public offering within five years, says new minority owner the Lundbeck Foundation.

Photo: Lundbeckfonden / PR

When Ferrosan Medical Devices was acquired by a consortium of investors comprising the Lundbeck Foundation, Kirk Kapital, and Danish pension firm ATP, the message was clear – they are in it for the long haul.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs